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The spirochetes Brachyspira hyodysenteriae and B. pilosicoli are pig intestinal
pathogens that are the causative agents of swine dysentery (SD) and porcine intestinal
spirochaetosis (PIS), respectively. Although some inactivated bacterin and recombinant
vaccines have been explored as prophylactic treatments against these species, no
effective vaccine is yet available. Immunoproteomics approaches hold the potential
for the identification of new, suitable candidates for subunit vaccines against SD and
PIS. These strategies take into account the gene products actually expressed and
present in the cells, and thus susceptible of being targets of immune recognition. In
this context, we have analyzed the immunogenic pattern of two B. pilosicoli porcine
isolates (the Spanish farm isolate OLA9 and the commercial P43/6/78 strain) and one
B. hyodysenteriae isolate (the Spanish farm V1). The proteins from the Brachyspira
lysates were fractionated by preparative isoelectric focusing, and the fractions were
analyzed by Western blot with hyperimmune sera from challenged pigs. Of the 28
challenge-specific immunoreactive bands detected, 21 were identified as single proteins
by MS, while the other 7 were shown to contain several major proteins. None of these
proteins were detected in the control immunoreactive bands. The proteins identified
included 11 from B. hyodysenteriae and 28 from the two B. pilosicoli strains. Eight
proteins were common to the B. pilosicoli strains ( i.e., elongation factor G, aspartyl-tRNA
synthase, biotin lipoyl, TmpB outer membrane protein, flagellar protein FlaA, enolase,
PEPCK, and VspD), and enolase and PEPCK were common to both species. Many
of the identified proteins were flagellar proteins or predicted to be located on the cell
surface and some of them had been previously described as antigenic or as bacterial
virulence factors. Here we report on the identification and semiquantitative data of
these immunoreactive proteins which constitute a unique antigen collection from these
bacteria.
Keywords: Brachyspira, vaccine, immunoblot, mass spectrometry, antigen, flagellar protein, swine dysentery,
spirochaetosis
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INTRODUCTION
Bacteria in the Brachyspiraceae family are gram-negative
and spiral-shaped Spirochaetes. Members of this phylum are
characterized by their unique motility and a loosely coiled
morphology caused by the existence of periplasmic flagella
(Charon and Goldstein, 2002). Species of the Brachyspiraceae
family are anaerobic, host-associated intestinal bacteria in
pigs, humans and other species, and can cause gastrointestinal
pathologies and mortality (Stanton, 2006). Currently, the
Brachyspiraceae comprises 16 species. B. hyodysenteriae
and B. pilosicoli are well-known Brachyspira intestinal
pathogens in pigs, responsible for swine dysentery (SD, a
severe mucohaemorrhagic colitis) (Alvarez-Ordóñez et al., 2013)
and porcine intestinal spirochaetosis (PIS, porcine spirochaetal
diarrhea, a mild, non-haemorrhagic colitis), respectively (Trott
et al., 1996; Stanton, 2006).
SD is produced by B. hyodysenteriae, a restricted pig-
associated species, and is a disease present worldwide that has an
important economic impact on the farming business. SD mainly
affects pigs in the growing-finishing periods. This contributes
to the high cost of the disease, which is associated not only
with mortality, which is relatively low when animals are treated
(Hamdy, 1974), but also with high morbidity, growth retardation
and the need for continual in-feed medication.
Unlike most Brachyspira species, B. pilosicoli has a wide host
range. It is zoonotic in pigs, poultry, dogs and humans (Hampson
et al., 2006), in which it can lead to intestinal spirochaetosis (IS).
In humans, the prevalence of IS is very uneven, much higher in
developing regions than in industrialized regions (Tsinganou and
Gebbers, 2010).
The treatment for the control of a Brachyspira infection
involves the use of multiple antimicrobial agents (Alvarez-
Ordóñez et al., 2013). Nevertheless, several studies have
highlighted the increasing occurrence of B. hyodysenteriae and
B. pilosicoli isolates resistant to these antibiotics in many
countries (Molnar, 1996; Karlsson et al., 2001; Rohde et al.,
2004; Hidalgo et al., 2009; Ohya and Sueyoshi, 2010; Pringle
et al., 2012), greatly compromising the efficacy of this global
treatment.
Since Joens et al. described that pigs that recovered from
SD acquired immunological protection, and therefore rarely
relapse when re-exposed to the infective agent (Joens et al.,
1979), several endeavors have been launched to design a vaccine.
Unfortunately, these attempts have not been successful to date,
and no effective vaccine against B. hyodysenteriae or B. pilosicoli
is available. Early approaches in this area included immunization
with an inactivated bacterin (Hampson, 2000) or attenuated
strains (Hyatt et al., 1994). In addition to conferring only
partial protection in the best cases, these strategies entailed a
cumbersome anaerobic-culture of Brachyspira which was not
appropriate for large-scale production.
In recent years, the development of subunit vaccines based
on Brachyspira recombinant proteins has also been explored.
Molecules studied included flagellar proteins such as FlaA and
FlaB (Boyden et al., 1989; Kent et al., 1989; Gabe et al., 1995; Ge
and Charon, 1997) and some structural and metabolic proteins,
such as outer-membrane proteins BmpB (La et al., 2004), SmpB
(Holden et al., 2008), or variable surface proteins (Vsp) (Witchell
et al., 2006, 2011). Similar to an attempt to formulate a vaccine
based on the ferritin protein FtnA (Davis et al., 2005), none
of these antigens provided enough protection for SD. On the
other hand, several surface proteins of B. pilosicoli (ClpX and two
putative oligopeptide-binding proteins) have been evaluated as
candidates for vaccination against IS (Movahedi and Hampson,
2007, 2010).
The recent publication of the genome sequences of
B. hyodysenteriae and B. pilosicoli provided a useful tool for
the exploration of new candidates for inclusion in vaccination
processes. To date, the genome sequence of 20 strains of
B. hyodysenteriae (including the reference strain WA1, ATCC
49526) (Black et al., 2015) and three strains of B. pilosicoli
(porcine isolates P43/6/78 and 95/1,000, and an avian isolate
B2904) (Wanchanthuek et al., 2010; Mappley et al., 2012; Lin
et al., 2013) have been published. The availability of these data
enables extensive in silico analysis to identify vaccine candidates,
which can then be expressed and tested together in a subunit
vaccine. The potential of this reverse vaccinology approach was
demonstrated by Song et al. who explored the development of
a vaccine against SD using a partial genome sequence of the
B. hyodysenteriae WA1 strain (Song et al., 2009). More recently,
a list of 33 ORF candidates to vaccine targets has been patented
(Bellgard et al., 2015). These genes were selected on the basis
of their homology with known amino acid sequences of surface
proteins, secreted proteins and virulence factors from other
species.
Despite these important advances on the genomic level, its
translation to proteomic knowledge of B. hyodysenteriae and
B. pilosicoli is still a challenge. Undoubtedly, future studies
focused on the description of Brachyspira proteomes will be
necessary to design an effective vaccination strategy. In this
regard, we recently characterized a subset of proteins exposed
on the cell surface (surfaceome) of B. hyodysenteriae and
B. pilosicoli (Casas et al., 2016). This will not only contribute
to select good candidates for a vaccine, but will also impart
biological knowledge about invasive and pathogenic mechanisms
of Brachyspira.
In this study, we extended our proteomic approach to identify
potential immunogenic proteins from B. hyodysenteriae and
B. pilosicoli. For this purpose we studied the immunoproteome
of two B. pilosicoli strains (the isolate OLA9 and the commercial
ATCC strain P43/6/78) and one B. hyodysenteriae isolate (isolate
V1). Cell lysates were fractionated using preparative off-gel
isoelectrofocusing and the fractions were separated by SDS-
PAGE. The gels were immunoblotted using pig immune-sera,
and the reactive bands were identified by mass spectrometry.
Brachyspira isolates came from Spanish farms. It was reported
that during 2001-2003, more than 30% of commercial pig
farms in Spain had at least one positive for B. pilosicoli or
B. hyodysenteriae (Carvajal et al., 2006). There is thus a major
concern in relation to intestinal diseases caused by Brachyspira
species in the country (Osorio et al., 2012, 2013), which is the
world’s fourth largest producer of pig meat and where the porcine
industry has a huge socioeconomic impact. We propose the
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reported proteins as suitable candidates to be included in vaccines
for the treatment of SD and porcine IS.
MATERIALS AND METHODS
Brachyspira Cultures
Two isolates of Brachyspira pilosicoli and B. hyodysenteriae
(strains OLA9 and V1, respectively) and a commercial
B. pilosicoli (ATCC strain P43/6/78, ATCC 51139) were
used for the immunoproteomics study. Three additional
B. hyodysenteriae strains (the commercial ATCC strains WA1
and B-78, and the isolate INF1) were included in the study of
Vsp profiles.
The isolates came from Iberian pigs that showed disease
symptoms on two different farms in the Badajoz province
(Spain). The medium for the isolation of Brachyspira was based
on the blood agar modified medium described by Calderaro et al.
(2001, 2005), supplemented with antibiotics to remove most of
the fecal micropopulation (Feberwee et al., 2008). The medium
was composed of blood agar base n◦ 2 (40 g/l) supplemented with
5% defibrinated horse blood (50 ml) (Oxoid, Thermo Scientific,
Waltham, MA, USA), beef extract (3 g/l), Bacto-peptone (5 g/l),
(Difco, BD, Franklin Lakes, NJ, USA) and spectinomycin (0.2
g/l), spiramycin (0.025 g/l), rifampicin (0.012 g/l) vancomycin
(6.2 g/l), and colistin (6.25 mg/l) (all from Sigma-Aldrich, St.
Louis, MO, USA) and 810 ml distilled water. The plates were
incubated for 4–7 days at 42◦C in an anaerobic jar with CO2
produced by an AnaeroGen TM 3.5 L (Oxoid, Thermo Fisher
Scientific, MA, USA). The colonies were examined by phase
contrast microscopy (40x). The isolates were characterized by
PCR using species-specific primers for nox (B. hyodysenteriae)
and 16S rRNA (B. pilosicoli) as previously described (Casas et al.,
2016) and stored at−80◦C.
Blood agar solid subcultures of the isolates were seeded
in Brain-heart infusion (BHI) broth (Laboratorios CONDA
Pronadisa, Torrejón de Ardoz, Spain) enriched with horse serum
(15%) and incubated with shaking in anaerobiosis jars at 4◦C for
4–7 days. The grown cultures were centrifuged at 12,900 × g for
10 min, and the pellet washed twice with TE buffer (10 mM Tris
pH 8.0, 1 mM EDTA, both from Sigma-Aldrich, St. Louis, MO,
USA). All bacterial growth and handling procedures were carried
out under biosafety level 2 conditions.
Brachyspira Cell Lysate and Protein
Quantification
Bacterial pellets (∼150 mg) were resuspended in 500 µl
denaturing lysis buffer containing 4% SDS, 0.1 M DTT and
100 mM Tris-HCl pH 7.5. After incubation in a Thermomixer
(Eppendorf model Comfort, 600 rpm, 1 h, 95◦C), the samples
were homogenized in a Bullet Blender (Next Advance Storm,
NY, USA) for 3 min at level 8, using 250 µl zirconium silicate
beads (0.1 mm diameter, BioSpec, 11079101z). The beads were
then pelleted by centrifugation at 14,000 × g for 3 min and the
Brachyspira cell lysate was recovered from supernatant.
Prior to protein quantification, the excess SDS was removed
from the sample using an SDS-Out TM Precipitation Kit (Thermo
Fisher Scientific). The sample was diluted with 100 mMTris-HCl
pH 7.5 (1/2 v/v) for this procedure and the SDS was precipitated
with the precipitation reagent (1/20 v/v). After incubation in
an ice bath for 20 min, the anionic detergent was pelleted by
centrifugation (10,000 × g, 10 min) and the Brachyspira SDS-
free lysate was recovered from supernatant. After clarification by
an additional centrifugation (10,000 × g, 1 min) in a spin cup
column, the cell lysate was aliquoted and kept at−40◦C until use.
A small aliquot was used to measure the protein concentration
using the Bradford method (Bio-Rad Laboratories, CA, USA).
Off-Gel Protein Fractionation
Proteins in the Brachyspira lysates were fractionated by off-gel
isoelectric focusing (Ros et al., 2002; Michel et al., 2003) using
an OFFGEL Fractionator 3100 (Agilent Technologies CA, USA).
For this procedure, 1mg of protein (ca. 120–140 µl of cell lysate)
was diluted to a final volume of 3.6 ml with a 1.25X protein
off-gel stock solution (PROSS 1.25X: 7 M urea, 2 M thiourea,
1.5 M glycerol and 0.1 M DTT) supplemented with ampholytes
(GE Healthcare Life Sciences, Barcelona, Spain). Large 24-cm
dry strips with a wide immobilized pH gradient of 3–10 units
(GE Healthcare Life Sciences) were used for the separation.
After placing the 24 well frame, the strips were rehydrated
with 50 µl/well of IPG strip rehydration solution (PROSS-
ampholytes 1X) for 15 min, and the sample was loaded by
pipetting 150µl/well. To have enough material for an immuno-
analysis, the experiments were carried out in triplicate so a total of
3mg of each Brachyspira isolate was processed. The samples were
focused for 36 h at 64 kVh with a maximum current of 50µA and
power of 200 mW (4,500 V final voltage). Twenty-four fractions
were collected per sample. Three replicates were fractionated per
sample. Triplicates of each fraction were pooled in a single tube,
aliquoted and stored at−40◦C.
Brachyspira-Challenge and Control Pig
Sera
Pig sera were provided by the company Laboratorios Larrasa S.L.
(Badajoz, Spain) in the frame of a project funded by the Spanish
Ministry of Economy and Competitivity (MINECO, IPT-2011-
0735-010000). Laboratorios Larrasa S.L. was in compliance
with Spanish legislation (R.D. 1201/2005 and Law 32/2007)
and EU Council Guidelines (2003/65/CE) for the use of
experimental animals. These sera were obtained from pigs from
a healthy herd in Extremadura (South-Western Spain) which
were inoculated at the age of 14 weeks with active viable cells of
B. hyodysenteriae strain WA1 (ATCC 49526) or the B. pilosicoli
porcine strain P43/6/78 (ATCC 51139). The serum was extracted
from challenged animals at 12 weeks post-infection. Five different
sera from each Brachyspira species challenge (B. hyodysenteriae-
challenge serum 1–5 and B. pilosicoli-challenge serum 6–10) were
used in this study.
SDS-PAGE Separation of Off-Gel IEF
Fractions
Five (for the WB analyses) or ten (for silver staining) microliters
of the off-gel fractions were separated by SDS-PAGE. A sample of
20 µl of total lysate (input) was also prepared as a control. The
samples were prepared in sample loading buffer (2% w/v SDS,
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10% glycerol, 0.002% w/v bromophenol blue and 25 mM Tris-
HCl pH 6.8), heated at 56◦C for 30 min and resolved on 12 or
7.5%-polyacrylamide gels.
Six replicates were done for each separation. The
protein bands in one replicate were visualized by mass
spectrometry-compatible silver staining (Shevchenko et al., 1996;
Casanovas et al., 2009). The other five replicates were used for
immunoblotting with the appropriate antisera.
Immunoblotting
After SDS-PAGE, the proteins in the gel were transferred
to a nitrocellulose membrane using an iBlot TM system (Life
Technologies, CA, USA). Following Ponceau staining of the
proteins (Sigma-Aldrich, St. Louis, MO, USA), the membrane
was blocked with TBS-T (20 mM Tris-HCl pH 7.5, 150 mM
NaCl and 0.2% Tween-20) containing 5% (w/v) skimmed
milk (1 h, room temperature). The membrane was incubated
with the appropriate pig serum diluted in blocking solution
(1/3,000 for control serum and 1/5,000 for Brachyspira challenge
serum) with gentle agitation (1 h, room temperature). The
membranes were incubated (1 h) with a Rabbit Anti-pig IgG
H&L horseradish peroxidase-conjugated secondary antibody
(Abcam ab6777, 1/5,000 in blocking solution) and visualized with
luminol.
Characterization of Immunoreactive Bands
Optical density (OD) profiles of the immunoblots and SDS-PAGE
gels for all fractions were acquired using ImageJ Version 1.47
(NIH). The profiles were measured between 15 and 100 kDa, and
the OD values were normalized relative to the total lane intensity.
The Rf value was determined with the Quantity One 1D Analysis
Software (Bio-Rad) and position of each band expressed as its
molecular mass calculated from the Rf value using molecular
mass markers. Calculations using bands for the same protein in
a gel showed an average coefficient of variation of 0.85% (n =
14) for the calculated mass. As a consequence, bands in different
lanes of the same gel with a mass difference less than 1.7%
(2 × standard deviation) were considered the same band and
numbered accordingly.
Bands observed in at least two OD profiles of challenge
sera but absent in control sera were designated as challenge-
specific, differential immunoreactive bands. Some bands were
also considered differential when also potentially present in only
one of the control sera but observed at a very low intensity.
Other bands observed both in the control and challenge sera
were considered as challenge-non-specific bands (Supplementary
Tables S1, S2).
Mass Spectrometry Analysis and Protein
Identification
Silver stained bands corresponding to the reactive bands detected
in the immunoblots were excised and digested using an automatic
device (DigestPro MS, Intavis, Cologne, Germany). The process
involved reduction with dithiothreitol, derivatization with
iodoacetamide, and enzymatic digestion with trypsin (37◦C, 8 h)
(Casanovas et al., 2009). The tryptic digests were evaporated
and redissolved in 5 µl of methanol/water/trifluoroacetic acid
(30/70/0.1 v/v).
Proteins in the tryptic digests (0.5 µl) were identified
by MALDI-TOF peptide mass fingerprinting combined with
MS/MS ion search in a 4800 TOF/TOF mass spectrometer
(ABSciex, Barcelona, Spain) in the reflectron mode. The spectra
were externally mass calibrated using a standard peptide mixture.
Alpha-cyano-4-hydroxycinnamic acid (3 mg/ml) was used as
the matrix. The five signals with the greatest intensity in
each MALDI-TOF spectrum were automatically analyzed by
TOF/TOF. The combined TOF and TOF/TOF spectra were
interpreted by database search (Mascot, Matrix Science, MA,
USA) using the following parameters: peptide mass tolerance,
50 ppm; fragment mass tolerance, 0.5 Da; fixed modification,
carbamidomethyl cysteine; variable modification, oxidation of
methionine; significance threshold of the MOWSE score, p <
0.05. All identifications were manually validated.
Samples which did not produce a positive identification by
MALDI were reanalysed by LC-MS/MS in a Velos-LTQ or
an Orbitrap-XL mass spectrometer (Thermo Fisher Scientific)
equipped with a microESI ion source. Four microliters of
each sample digest were diluted to 20 µl with 5% methanol
and 1% formic acid, and loaded into a chromatographic
system consisting of a C18 preconcentration cartridge (Agilent
Technologies) connected to a 15-cm long, 150 µm i.d. (Velos-
LTQ) or 100 µm i.d. (Orbitrap-XL) C18 column (Nikkyo
Technos Co.). The separation was performed at 1 µl/min
(Velos-LTQ) or 0.4 µl/min (Orbitrap XL) in a 30-min gradient
from 3 to 40% acetonitrile (solvent A: 0.1% formic acid,
solvent B: acetonitrile 0.1% formic acid). The instruments were
operated in the positive ion mode with a spray voltage of
1.5 kV. The spectrometric analysis was performed in a data
dependent mode. The scan range for full scans was m/z 400–
1,800. The LC-MS/MS spectra were searched using SEQUEST
(Proteome Discoverer v1.4, Thermo–Fisher Scientific) with the
following parameters: peptide mass tolerance, 1 Da (Velos-LTQ)
or 20 ppm (Orbitrap-XL); fragment tolerance, 0.6 Da; enzyme,
trypsin; two missed cleavages allowed; dynamic modification,
methionine oxidation (+16 Da); fixed modification, cysteine
carbamidomethylation (+57 Da). The peptide identifications
were filtered at 0.1% FDR and only proteins identified with
two or more peptides and peptide rank 1 were considered.
Relative abundance of the identified proteins in each sample
was roughly estimated from the product of the total peptide
sequence matches pointing to that protein and its sequence
coverage. The group of more abundant proteins bearing
more than 80% of the total abundance in the sample were
considered for discussion (Full data is available in Supplementary
Tables S3–S9).
Searches for the MALDI and LC-MS/MS methods described
above were carried out against the Uniprot database (2015_11
version) restricted to Brachyspira. When results pointed to
indistinguishable different accessions to the same protein in
different strains, the accession for the reference ATCC strains was
reported in Table 1, Supplementary Tables S1, S2.
Mass Spectrometry Target Analysis of Vsp
Proteins
LC-MS/MS analyses of Vsps were carried out in a Velos-
LTQ using the configuration described above for protein
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TABLE 1 | Proteins identified in the immunoreactive bands from the two Brachyspira species.
Band ida Sample Specificb Observed Mass (kDa) Protein identified
12% 7.5% Accessionc Name Theor. Mass (kDa)
2 OLA9 X 86 76 D8ICZ7 Elongation factor G 75.8
3 OLA9 83 D8IDC2 Uncharacterized protein 62
4 ATCCBP X 81 78 D8ICZ7 Elongation factor G 75.8
5* OLA9 X 78 72 J9UT37 Putative polymerase 72.3
D8IEM8/ Chaperone protein HtpG 73.9
A0A0G4K4U5
D8IBS0 Chaperone protein DnaK 67.6
6 ATCCBP 77 D8IDC2 Uncharacterized protein 62
7 OLA9 75 D8IDC2 Uncharacterized protein 62.1
9 V1 73 G0EJY7 Uncharacterized protein 65.4
10* ATCCBP X 72 70 D8IEM8 Chaperone protein HtpG 73.9
J9UT37 Putative polymerase 72.3
D8ICG5 Uncharacterized protein 85
12 V1 72 C0R0R7 Putative treponemal membrane protein 63.9
13 OLA9 X 72 68 D8IE58 Aspartyl-tRNA synthase 67.5
15 ATCCBP 69 D8IDC2 Uncharacterized protein 62.1
16 ATCCBP X 69 D8IFS5 Phosphoenol pyruvate carboxykinase 67.5
17 ATCCBP X 69 70 D8IE58 Aspartyl-tRNA synthase 67.5
18 V1 X 68 C0R0E5 Phosphoenol pyruvate carboxykinase 67.5
19 OLA9 X 65 D8I9T6 Biotin lipoyl 65
20 OLA9 64 61 D8IB78 60 kDa chaperonin 58.1
22 ATCCBP X 63 D8I9T6 Biotin lipoyl 65.0
24 ATCCBP 62 61 D8IB78 60 kDa chaperonin 58.1
25 V1 61 C0QWH4 60 kDa chaperonin 58.2
26* OLA9 X 58 53 J9USS2 60 kDa chaperonin 58.1
D8IAM3 Amidohydrolase 3 60.6
J9UU81 2-isopropylmalate synthase 54.4
D8IF78 Outer membrane efflux protein 54.7
D8IDP7 Trigger factor, C-terminal domain protein 50.6
27 OLA9 X 57 D8IBK7 TmpB outer membrane protein 42.5
28 ATCCBP X 56 55 K0JIZ9 Carboxyl terminal protease 54.9
29* ATCCBP X 54 D8IBK7 TmpB outer membrane protein 42.4
31 ATCCBP X 51 50 D8IBH9 ATP synthase subunit beta 45.6
32 ATCCBP X* 50 D8IET2 Enolase 47
36 V1 X 45 C0QW84 Uncharacterized protein 38.6
37 OLA9 44 Q9FA06 Putative elongation factor Tu 16.3
D8ICZ6 Elongation factor Tu 44.8
38 ATCCBP 44 Q9FA06 Putative elongation factor Tu 16.3
D8ICZ6 Elongation factor Tu 44.8
39 ATCCBP X 44 D8ICG3 Uncharacterized protein 38.9
40 OLA9 X 43 42 D8IBY6 FlaA 35.7
41 V1 43 C0QVZ4 Elongation factor Tu 44.7
Q9FA06 Putative elongation factor Tu 16.3
42 V1 42 C0QXS8 NADH oxidase 50.5
C0QVZ4 Elongation factor Tu 44.7
43 V1 42 C0R0T5 FlaA 24.5
P32520 FlaA1 36
44 ATCCBP X 41 D8IBY6 FlaA 35.7
45 OLA9 X 40 38 D8ICU0 VspD 42.7
(Continued)
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TABLE 1 | Continued
Band ida Sample Specificb Observed Mass (kDa) Protein identified
12% 7.5% Accessionc Name Theor. Mass (kDa)
46* ATCCBP X 38 38 D8ICU0 VspD 42.7
J9TU32 Ribonucleotide-diphosphate reductase
subunit beta
41.1
D8IEW7 Mannose-1-phosphate
guanylyltransferase
40.5
J9URY6 2-oxoacid:ferredoxin oxidoreductase
subunit alpha-like protein
82.8
J9UBH8 ATP-dependent 6-phosphofructokinase 34.8
D8ICA2 Toxic anion resistance family protein 40.9
D8I9T4 Uncharacterized protein 39.9
D8ICR1 Pyruvate oxireductase 35.5
47 OLA9 36 D8IAP2 Flagellin FlaB2 32
48 V1 X 35 C0R1L9 UDP-glucose 4 epimerase 36
C0QYC2 Galactose-glucose binding protein 38.2
49 ATCCBP 35 D8IAP2 Flagellin FlaB2 32
50 V1 35 Q26501 FlaB1 32
51* V1 X 35 A0A0H0W3D6 Enolase 47
Q26501 Flagellar protein FlaB1 32
A0A0HOUMF4/
G0EJK5
Fructose-bisphosphate aldolase 35.4/35.4
C0QYC2 Methyl-galactoside ABC transporter
substrate-binding protein
38.2
C0QZV6 Pseudouridine-5’-phosphate glycosidase 33.9
52 OLA9 X* 33 D8ICA8 Putative FlaA 26.7
53 OLA9 32 K0JHQ4 Flagellin FlaB2 31.3
54 V1 31 P80160 Flagellin FlaB2 31.1
55 ATCCBP 31 K0JHQ4 Flagellin FlaB2 31.3
56 OLA9 29 K0JLS4 Flagellin FlaB3 30
57 V1 X* 29 C0QV52 Enolase 47
Q9F0F6 Flagellin FlaB3 30.4
58 ATCCBP 29 D8IDG1 Flagellin FlaB3 26.6
59 V1 29 Q9F0F6 Flagellin FlaB3 30.4
61 V1 X 26 C0QWY9 Putative FlaAL 24.7
62 ATCCBP X 24 D8ICA7 FlaA-2 24
Complete identification data is available in Supplementary Table S1 (MALDI TOF/TOF) and Supplementary Tables S3–S9 (LC-MS/MS). Specific, indicates immunoreactivity is only
detected in challenged animals. Observed mass, correspond to the experimental mass calculated from the gel bands. ATCCBP, ATCC 51139 (P43/6/78) B. pilosicoli strain.
aAll identifications by MALDI TOF/TOF except those indicated with an asterisk which were identified by LC-MS/MS.
bSpecific bands with X* have been detected in a control serum with an intensity of one.
cGroup head accession, full data in Supplementary Tables S1, S2.
identification. The equivalent to 1 µg of protein in 20 µl
of 5% methanol, 1% formic acid was loaded into a system
and a 120-min acetonitrile gradient from 0 to 40% was used.
The spectrometric analysis was performed in the target mode,
acquiring the MS/MS scans of the signals included in the
corresponding mass list (Supplementary Table S10). The mass
list for each species included at least two unique peptides for
each Vsp protein. Potential peptide targets detected in previous
shotgun analyses were preferentially selected to build the mass
lists. Other targets were selected among the best proteotypic
peptides predicted by the PeptideRank software (Qeli et al.,
2014).
RESULTS
Protein Fractionation of B. pilosicoli and
B. hyodysenteriae Strains and Selection of
Immunogenic Fractions
Proteins from the cell lysates were fractionated by preparative
isoelectric focusing (IEF) prior to SDS-PAGE. Via this technique,
we could fractionate up to 1mg of each Brachyspira lysate
using 24-cm pH 3-10 Immobiline Drystrips. The Off-gel system
provided adequate resolution and reproducibility for protein
fractionation as verified in a parallel study in which replicate
SDS-PAGE analyses were carried out on an arbitrary selection
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of 7 out of the 24 fractions collected (Supplementary Figure S1).
This reproducibility allowed the pooling of fractions from the
three independent IEF fractionations, thereby providing of the
equivalent of a total of 3mg of fractionated proteins for each
Brachyspira strain.
To select the fractions that contained the immunogenic
proteins, the 24 recovered fractions were immunoblotted with
sera from pigs challenged with B. pilosicoli (serum 6–10, for
OLA9 and ATCC 51139 fractionations) or B. hyodysenteriae
(serum 1–5 for V1 fractionation). Most of the immunogenic
bands from the three Brachyspira strains appeared in the
early-middle fractions (numbers 3–13) that had isoelectric
points between 3.5 and 6.5 (Figures 1, 2 and Supplementary
Figure S2). Note that for all strains, an immunoblot analysis
with control serum from non-challenged pigs also revealed
some reactive bands (Supplementary Figure S3). This
cross-reactivity was consistent with previous reports that
showed that healthy pig serum detects B. hyodysenteriae
surface antigens (Wannemuehler et al., 1988) or some of the
recombinant proteins tested for a vaccine against SD (Song et al.,
2009).
Protein Identification
IEF fractions from the different Brachyspira strains showing
the highest immunogenic response (fractions 4–9, 11, 13 and
3–9, 11–12, for B pilosicoli and hyodysenteriae respectively)
(Figures 1, 2) were selected for a more detailed image analysis
and band characterization. For this purpose, these fractions were
reanalysed by SDS-PAGE and immunoblotted. Immunoreactive
bands were identified by densitometry and the immunoblot
images were matched with those obtained by silver staining
on replicate SDS-PAGE separations (Figures 3, 4). The bands
were then excised, trypsin digested and analyzed by mass
spectrometry. Overall the components in 51 gel bands (36 from
B. pilosicoli and 15 from B. hyodysenteriae strains) were identified
(Table 1, Supplementary Tables S1–S9).
Most of the bands (45) could be identified by MALDI,
except for six of them that required an LC-MS/MS analysis. The
failure of MALDI in the analysis of these bands was probably
due to the presence of several major proteins in the band
as confirmed from the LC-MS/MS identification data. Thus,
when LC-MS/MS identifications were filtered to select the most
abundant components, only one of these bands produced a single
protein while the others showed the presence of 3–8 major
components.
B. pilosicoli Immunoreactive Proteins
Sixteen and 20 immunoreactive bands were detected for
the B. pilosicoli OLA9 and ATCC 51139 strains, respectively
(Supplementary Figures S4, S5A–F and Table 1, Supplementary
Tables S1, S2). Several of these bands were common to
both strains. Some of the fractions (#8 and #9) showed a
complex profile at the high mass range of the silver-stained
gels. To increase the resolution of the more complex
fractions, parallel SDS-PAGE and Western blot analyses
were carried out using 7.5% acrylamide gels (Figure 5,
Supplementary Figures S5B,E). The mass spectrometric
analysis of the corresponding silver-stained SDS-PAGE bands
(Figures 3, 4) produced the identification of 28 different proteins
in challenge-specific immunoreactive bands (Table 1). Eighteen
of the immunoreactive specific bands yield a single protein (7 for
OLA9 and 11 for ATCC 51139), while 4 other bands were shown
to contain more than one protein.
The two B. pilosicoli strains shared eight proteins in common
in the bands with specific reactivity toward the challenge sera (the
outer membrane protein of the TmpB family, a flagellar filament
outer layer protein FlaA, the variable surface protein VspD, the
chaperone protein htpG, a putative polymerase, the aspartyl-
tRNA synthase, the biotin lipoyl and the elongation factor G)
(Table 1).
Seven other proteins common to both strains were found
in challenge-non-specific bands including a 60 kDa chaperonin,
flagellins B2 and B3 and the elongation factor Tu.
B. hyodysenteriae Immunoreactive
Proteins
Fifteen immunoreactive bands were detected in the selected
IEF fractions from the B. hyodysenteriae farm isolate V1 using
sera from B. hyodysenteriae-challenged animals (Figures 3, 4,
Supplementary Figures S4, S5G,H). Six of these bands showed
challenge specific immunoreactivity (#18, #36, #48, #51, #57,
#61) while nine others also cross-reacted with control sera
from healthy pigs (#9, #12, #25, #41, #42, #43, #50, #54,
and #59). Three of the challenge-specific bands, produced a
single protein identification, while the other bands were shown
to contain several proteins up to a total of 11 (Table 1,
Supplementary Tables S1–S9). Among the challenge-specific
proteins PEPCK (phosphoenolpyruvate carboxykinase) and
enolase had also been identified as antigenic in the B. pilosicoli
isolates.
Cross-Reactivity with Control Sera
For all strains, the immunoblots with sera from control, non-
challenged pigs also revealed several immunoreactive bands
(Supplementary Figure S3).
Cross-reactivity was observed for all flagellar proteins except
B. pilosicoli FlaA. The FlaB proteins were the primary targets of
the control sera for B. pilosicoli and B. hyodysenteriae (Table 1,
Supplementary Tables S1, S2). The three isoforms of FlaB that
constitute the inner core of the spirochaetal flagella (FlaB1, FlaB2,
and FlaB3) were identified in the immunoreactive bands (Table 1,
Figure 4).
Other proteins immunoreactive to control sera were
Elongation factor Tu, which was detected in both species and the
uncharacterized protein D8IDC2, which was identified in the
two B. pilosicoli strains.
Distribution of Vsp Among Brachyspira
Species and Strains
Although the variable surface protein VspD has been suggested
as a potential vaccine candidate against B. hyodysenteriae we
could only identify VspD in the immunoreactive bands from
B. pilosicoli samples (Table 2, Supplementary Tables S11–S17).
To confirm these findings, a more detailed LC-MS/MS analysis
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FIGURE 1 | General view of the immunoreactive proteins in each of the IEF fractions of the protein extracts of OLA9 (top) and ATCC 51139 (bottom)
B. pilosicoli strains. The images are examples of the Western blots prepared with sera #1 and #8 (from a control and a challenged animal, respectively) (upper and
lower gels for each strain). Twenty four consecutive IEF protein fractions, covering a pI range from 3 to 10, were analyzed in the corresponding lanes of three
SDS-PAGE gels. Fractions presenting intense immunoreactive bands in these preliminary experiments were submitted to a detailed immunoproteomics analysis using
all the individual sera available. The Figure shows only the images for the two first gels (lanes for IEF fractions 1–16), containing the more acidic fractions, and the lane
corresponding to the crude proteome extract (lane Inp). IEF fractions 17–24 did not show relevant immunoreactive bands (complete images for all the fractions and
individual sera tested can be found in Supplementary Figures S2A–C).
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FIGURE 2 | General view of the immunoreactive proteins in each of the IEF fractions of the protein extracts of the B. hyodysenteriae strain V1. The
images correspond to examples of the Western blots prepared with sera #1 and #5 (a control and a challenged animal, respectively) (upper and lower gels for each
strain). Fractions presenting intense immunoreactive bands in these preliminary experiments were submitted to a detailed immunoproteomics analysis, see Figure 1
for details. Inp, lane corresponding to the crude extract before IEF separation.
FIGURE 3 | Identification of immunoreactive proteins in the IEF fractions of the Brachyspira proteomes. The image shows the Western blot densitometry
profiles (top and bottom) and the protein band profile of the corresponding silver-stained gel lane (center). Immunoreactivity traces for the 5 sera from challenged
pigs (top) and the 3 sera for control pigs (bottom) are shown with different colors (see SI for color codes). Bands identified as immunoreactive were sliced from the
SDS gel lane and submitted to MS analyses for identification. Code numbers for the bands analyzed from these specific lanes are indicated in red. The example given
corresponds to the IEF fractions #6 from ATCC 51139 (B. pilosicoli) (left) and V1 (B. hyodysenteriae) (right) strains. The full set of images for all the fractions is given in
Supplementary Figures S5A–H.
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was performed targeting the family of Vsp proteins. For this,
each Vsp protein was monitored by targeting two or more
tryptic peptides with sequences unique to that specific protein
(Supplementary Table S10). Three strains of B. hyodysenteriae
(two commercial ATCC strains and one isolate) and two strains
of B. pilosicoli (one commercial ATCC strain and one isolate)
were analyzed.
The analysis showed that the profile of Vsp proteins was
very variable between species and strains (Table 2). In agreement
with our previous results, VspD, was highly abundant in both B.
pilosicoli strains (more than 200 PSMs per strain). Contrarily, it
was detected with a very low abundance (<25 PSMs) (Table 2,
Supplementary Tables S13, S17) in only one of the three
B. hyodysenteriae strains (WA1). Another proposed vaccine
candidate in this family, VspH, was found in both species but not
in all strains.
The vspC and vspF genes have not been described in B.
pilosicoli. Both proteins were detected in B. hyodysenteriae
FIGURE 4 | Summary of the analyzed bands from SDS-PAGE silver
stained gels for the selected IEF fractions of OLA9 strain (B. pilosicoli)
and V1 strain (B. hyodysenteriae).
although the expression was strain-dependent. VspC was
detected in the commercial strains (range 25–100 PSMs),
but not in the isolate. To the best of our knowledge,
this result constitutes the first experimental evidence at the
protein level of the expression of this protein. On the
other hand, VspF was found to be greatly abundant in the
B. hyodysenteriae WA1 strain but was not detected in the
others. This is similar to reports by Black et al. (2015), who
described the absence of the vspF gen in some strains from
B. hyodysenteriae. According to Witchell et al. (2011), VspF
and VspE are found in the cell in a protein complex which
can include also other Vsps. Differently to the other members
discussed above, VspE was detected in both species and in all
strains.
We could not identify VspA, VspG, or VspJ in any of the
strains analyzed. Another member, VspB, described from the
genome of B. hyodysenteriae was detected in all strains but with a
very low abundance.
FIGURE 5 | Detailed analysis of the high-mass proteins in IEF fractions
#8 and #9 from ATCC 51139. IEF fractions #8 and #9 from B. pilosicoli
showed unresolved, complex profiles of bands in 12% acrylamide gels (up).
These profiles were resolved by a parallel analysis of these fractions in 7.5%
acrylamide gels (down). Data from the 12% and 7.5% separations were later
combined. The example shown corresponds to IEF fraction #8 (see Figure 3
for details).
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TABLE 2 | Presence of Vsp proteins in Brachyspira strains.
B. hyodysenteriae B. pilosicoli
WA1 B-78 INF1 ATCCBP OLA9
Protein Collection Collection Isolate Collection Isolate
VspA nd nd nd na na
VspB *a *a *a na na
VspC ** ** nd na na
VspD * nd nd *** ****
VspE * ** ** ** *
VspF **** nd nd na na
VspG nd nd nd na na
VspH nd ***a nd ** nd
VspI ? ? ** na na
VspJ nd nd nd na na
Asterisks indicate total number of peptide sequence matches (PSM) for the protein (*, 0–
25 PSM; **, 25–100 PSM; ***, 100–300 PSM; ****, > 300 PSM). PSM is correlated with
protein abundance. ATCCBP, ATCC 51139 (P43/6/78) B. pilosicoli strain.
a Identified from only one protein-exclusive peptide.
nd, not detected; na, not monitored (sequence not described for the species).
?, Identified from only one, non-protein-exclusive peptide (common with VspA).
DISCUSSION
Challenge-Specific Immunoreactive
Proteins Common to Both Brachyspira
Species
Two proteins (PEPCK and enolase) were revealed by challenged
sera from both Brachyspira species. These proteins showed
a high degree of identity between species (96% identity for
B. hyodysenteriae and B. pilosicoli enolases and 95% of identity
for the corresponding PEPCK).
In a vaccine search, candidates are often selected from
membrane-exposed proteins, because surface exposure facilitates
recognition by an antibody (Boyle et al., 1997). Still, many
cytosolic proteins have been described as major antigens and
some of them have also been explored as vaccine components
(Davis et al., 2005). In our study, many of the proteins
detected were proteins annotated as cytoplasmic. This is the
case for PEPCK, whose antigenic capacity had been previously
reported in other species. PEPCK was identified as the antigen
triggering the cellular response responsible for the hepatic
granulomatous inflammation in schistosomiasis (Asahi et al.,
2000). Additionally, PEPCK from Mycobacterium tuberculosis
has been demonstrated to induce a strong immune response in
mice and, for this reason, was proposed as a component of a
subunit vaccine for tuberculosis (Liu et al., 2006).
Enolase has been reported to be immunoreactive in several
pathogenic species, such as Mycobacterium tuberculosis (Rahi
et al., 2017), and Borrelia burgdorferi (Barbour et al., 2008). This
protein has also been described as a differential, immunogenic
protein in strains of Bifidobacterium longum ssp. longum (Górska
et al., 2016) and showed protective activity against colitis in mice
(Srutkova et al., 2015). Enolase is a moonlighting enzyme found
on the surface of some pathogens and involved in the activation
of plasminogen (Rahi et al., 2017). In a previous work (Casas
et al., 2016), we reported enolase to be among the ten most
abundant proteins detected in the surfaceome and exoproteome
compartments for B. pilosicoli and B. hyodysenteriae.
These two proteins are thus tentative candidates for vaccines
against Brachyspira infections that have not been included in
earlier reported vaccines.
Two other putative uncharacterized proteins (C0QW84 and
D8ICG3) were identified in challenge-specific bands (bands #36
and #39, respectively) (Figure 4) from B. hyodysenteriae and
B. pilosicoli, respectively. Both are predicted (PSORTb v3.0 (Yu
et al., 2010), SignalP v4.1 (Petersen et al., 2011) to be extracellular
or located on the outer membrane, although C0QW84 lacks the
signal peptide on the N-terminal side. These proteins have the
same molecular weight and isoelectric point and 62% of identity
and 72% similarity between them, suggesting they are different
forms of the same functional molecule in these species. In this
case, a potential vaccine candidate common to both species
would require identifying possible common epitopes capable of
inducing an immune response.
B. pilosicoli Challenge-Specific
Immunoreactive Proteins
Twenty-eight B. pilosicoli proteins were identified in the
challenge-specific bands, with 8 of them common to the ATCC
51139 and environmental OLA9 strains. More than half of
these proteins could be identified as proteins potentially exposed
on the surface of the bacteria or secreted into the media.
Thus, 9 corresponded to known or predicted (Gene Ontology
Annotation (GOA), PSORTb) membrane or membrane-exposed
proteins (TmpB outer membrane protein, outer membrane
eﬄux protein, VspD, enolase, D8ICG5, D8ICG3) or flagellar
proteins (FlaA, FlaA2, D8ICA8) (Supplementary Table S2). Six
of these proteins (ATP-dependent 6-phosphofructokinase, 2-
isopropyl malate synthase, chaperone protein DnaK, pyruvate
oxidoreductase, enolase and VspD) were identified in a previous
work among the most abundant proteins in the exposed
proteome of these bacteria (Casas et al., 2016). Especially
VspD, similar to enolase, was among the 10 most abundant
proteins exclusively found on the exoproteome (i.e., proteins
present in the bacterial culture media). Variable surface
proteins constitute a well-known family of antigenic bacterial
components. However, no evidence at the protein level had
been previously reported for the expression of any Vsp protein
in B. pilosicoli.
The treponemal outer membrane protein B (TmpB, D8IBK7)
was identified as challenge-specific for both B. pilosicoli strains.
Two putative treponemal membrane proteins (C0R0R7 and
C4MGG7) with 47 and 55% homology with B. pilosicoli
TmpB were included in a reverse vaccinology study against
B. hyodysenteriae, but they were not immunoreactive when
immunoblotted with porcine sera from challenged animals (Song
et al., 2009). Contrarily, we detected C0R0R7 in immunoreactive
bands of B. hyodysenteriae.However, this reactivity was observed
toward both the challenge and control sera, so this protein was
discarded as a specific vaccine candidate.
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The flagellar protein FlaA was also found in the
immunoreactive bands of both B. pilosicoli strains. FlaA
constitutes the outer sheath of periplasmic flagella in spirochetes,
impacting the unusual morphology and motility of this bacterial
phylum (Li et al., 2000, 2008; Rosa et al., 2005; Jiang et al., 2014;
Zhao et al., 2014). Flagellar proteins are major immunoreactive
proteins in B. hyodysenteriae (Kent et al., 1989). It has been
reported that FlaA from S. hyodysenteriae, S. innocens, and
S. pilosicoli was recognized by rabbit polyclonal and murine
monoclonal antibodies produced against S. hyodysenteriae
lysates (Fisher et al., 1997). However, no data were previously
available on the antigenicity of B. pilosicoli FlaA. In our study,
both B. pilosicoli and B. hyodysenteriae FlaA were found in
immunoreactive bands although only B. pilosicoli evidenced a
challenge-specific response.
Two other cytoplasmic proteins, the chaperone protein HtpG
and aspartyl tRNA synthase, were found to be immunogenic
in both B. pilosicoli strains. HtpG has been reported to
be responsible for a strong humoural response in human
periodontitis caused by Porphyromonas gingivalis (Shelburne
et al., 2008). On the other hand, aminoacyl tRNA synthases
are the targets of many antibacterial compounds (Chopra
and Reader, 2014). They play an important role in bacterial
resistance as described for Mycobacterium tuberculosis strains
where mutations in this protein are involved in their resistance to
whole-cell inhibitors (Ioerger et al., 2013). No data were available
on the antigenicity of these molecules.
B. hyodysenteriae Challenge-Specific
Immunoreactive Proteins
Flagellar proteins were the most frequent class of
immunoreactive proteins identified in B. hyodysenteriae
(Table 1, Supplementary Tables S1, S2). However, except for a
putative flagellar filament outer layer-like protein (C0QWY9),
other flagellar proteins identified such as FlaA1, FlaB1, and FlaB3
were also found in bands immunoreactive toward control sera.
FlaA1 had been previously described as one of the molecules that
produced a highly specific immune reaction in B. hyodysenteriae
(Li et al., 1993).
Other proteins detected in the challenge-specific
immunoreactive bands included the galactose-glucose binding
protein, a periplasmic protein, and two cytoplasmic proteins,
pyridine nucleotide-disulfide oxidoreductase and fructose-
bisphosphate aldolase. These proteins have been detected in
the extracellular space in other species involved in processes
related to the interaction/ adhesion to the host cell (Tunio et al.,
2010; Roier et al., 2015; Zhe et al., 2016). The galactose-glucose
binding protein was identified as the main component of
the outer membrane vesicles released from 5 different strains
of Haemophilus influenza (Roier et al., 2015). Extracellular
nanovesicles are released by all pathogenic and non-pathogenic
gram-negative bacteria (Lusta, 2015). They are composed of
outer membrane components such as LPS, glycerophospholipids
as well as proteins from the outer membrane and the periplasm
(Kuehn and Kesty, 2005; Bai et al., 2014; Lusta, 2015). Outer
membrane vesicles are considered as potent virulence factors
because they provide a means for the extracellular secretion of
proteins and lipids that can interact with the host tissues. The
pyridine nucleotide-disulfide oxidoreductase (Zhe et al., 2016)
has been identified as one of the proteins that interacts with
brain microvascular endothelial cells, which may contribute to
invasion by Streptococcus equi ssp. zooepidemicus through the
blood-brain barrier. Finally, fructose-bisphosphate aldolase has
been reported to be immunogenic in Candida albicans (Calcedo
et al., 2012) and Madurella mycetomatis, in which it has been
proposed as a vaccine candidate (de Klerk et al., 2012).
Vsp proteins are the most abundant outer membrane proteins
of B. hyodysenteriae (Gabe et al., 1998), in which they have
been postulated to have an antigenic role either as protein
complexes or as individual molecules (McCaman et al., 1999;
Witchell et al., 2011). Twomembers of the Vsp family, VspH, and
VspD, have been included as components of a potential vaccine
against B. hyodysenteriae (Bellgard et al., 2015). However, little
is known about the expression of these proteins in Brachyspira
species. The expression of VspH was reported in a B204 strain
of B. hyodysenteriae (Witchell et al., 2006), although in further
studies they described the absence of the gene in other strains
(ATCCWA1 and X576) (Witchell et al., 2011). In the latter study,
the expression of the VspD protein (together with vspF, vspE,
and vspI) in a virulent Australian isolate of B. hyodysenteriae
(Witchell et al., 2011) was reported. These authors suggested that
Vsp proteins form complexes and that they are immunoreactive
only in that form.
Interestingly, the analysis of our immunoreactive bands
identified VspD only in the B. pilosicoli samples. This was in
agreement with our previous work (Casas et al., 2016) on the
exposed proteomes of B. pilosicoli and B. hyodysenteriae. In that
study, the VspD protein was classified as exclusive from the
exoproteome of B. pilosicoli because it was not found in any
compartment of B. hyodysenteriae. To confirm our findings about
the differential presence of VspD and to depict the distribution
of the Vsp proteins in different Brachyspira strains, a more
detailed targeted LC-MS/MS analysis was performed. The study
confirmed the high expression of VspD in both B. pilosicoli
strains and the low or no expression in B. hyodysenteriae strains.
Thus, Vsp proteins have a broad expression profile in
different strains and species, a trait that could determine
the efficiency of proteins such as VspH or VspD as vaccine
components. Vsp proteins are components of a mechanism used
by pathogenic bacteria to adapt to host conditions and optimize
colonization. These proteins can show reversible on/off switching
of their expression (phase variation) or antigenic changes by
the expression of alternative protein phenotypes (Lysnyansky
et al., 2001). Variability in the expression of variable surface
proteins has been reported for several species ofMycoplasma. In
in vitro experiments withMycoplasma bovis, it was observed that
exposure of the bacteria to anti-Vsp antibodies induced a change
in the Vsp expression pattern (Caswell et al., 2010). Vsp proteins
are the major antigenic targets inMycoplasma bovis, however the
immune response observed was not protective. In Mycoplasma
mycoides, the different Vsp expression pattern observed in several
outbreaks was suggested to be related to different Vsp proteins
triggering the immune response in each case (Hamsten et al.,
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2008). These facts stress the value of determining the actual
gene product levels present under different conditions as a
complement of genomic-based approaches for vaccine design.
Cross-Reactivity with Control Sera
We observed immunoreactive bands using control sera from
non-challenged pigs with all strains tested (Supplementary Figure
S3). This was consistent with previous reports showing that
healthy pig serum can detect B. hyodysenteriae surface antigens
(Wannemuehler et al., 1988). Song et al. also observed that non-
vaccinated pigs from a herd with no reported history of SD
developed increasing systemic lgG and lgM levels to all antigens
of a vaccine being tested as the body weight of the animals
increased (Song et al., 2009).
The FlaB family of proteins was the primary target of
control sera in both species. This finding could be related with
reports indicating that endoflagellar FlaBs, but not FlaA, from
B. hyodysenteriae cross-react with the corresponding proteins
from the non-pathogenic B. innocens (Li et al., 1993). In fact, it
has been shown that the immunoreactivity patterns of purified
flagellar proteins from different strains of B. hyodysenteriae and
several non-pathogenic spirochetes have similar distributions,
suggesting the existence of shared epitopes in these species (Kent
et al., 1989). Thus, the observed cross-reactivity of flagellar
proteins could be due to exposure to other non-pathogenic
bacteria. Vaccination of pigs with the endoflagellar protein FlaB1
(recombinant or purified from B. hyodysenteriae) generated
antibodies against the protein (Gabe et al., 1995). However, that
response was not sufficient to protect the animals against the
disease. It was suggested that the efficiency of the anti-FlaB
antibodies would be reduced by the reduced accessibility to the
inner part of the B. hyodysenteriae flagella (Gabe et al., 1995).
Other identified targets of the control sera were the Elongation
factor Tu and the uncharacterized protein D8IDC2. Elongation
factor Tu, is a protein which is conserved in different bacterial
species so its detection with sera from pigs that had not been
infected with SD or IS is not surprising. This protein has been
detected on the surface of Leptospira interrogans (the spirochete
which is the aetiological agent of leptospirosis) and it is related
to the binding with the host plasminogen (Wolff et al., 2013). It
is interesting to note that D8IDC2, which was identified in the
two B. pilosicoli strains, has a 97% of homology with Bpmp-72,
a membrane protein whose sequence was patented by Hampson
and La (2009) for its use as a vaccine and a therapeutic treatment
against intestinal spirochaetosis.
CONCLUSIONS
The immunoproteomics approach applied in this study has been
demonstrated to be very effective for the characterization of
new Brachyspira antigens. Data reported here was restricted
to IgG’s immunoreactivity toward these molecules. Further
studies focussing on serum and secretory IgA’s could potentially
increase this collection of potential candidates. Most previously
reported vaccine candidates were selected on the basis of
previous knowledge from other species and through in
silico reverse vaccinology approaches. The advantage of an
immunoproteomics approach is that it intrinsically takes into
account the actual expression levels, molecular characteristics
and exposure to the host of the specific antigens that elicit an
immune response. Consequently, the immunoreactive proteins
described are unrivaled candidates to be components of vaccines
for the treatment of SD and porcine IS. As discussed, we
identified two abundant antigenic proteins shared by the
two Brachyspira species (enolase and PEPCK) that could be
considered as candidates for common vaccines for these species.
In addition, 8 and 11 challenge-specific immunoreactive proteins
were described for Brachyspira pilosicoli and B. hyodysenteriae,
respectively. Although some of the immunoreactive bands were
shown to contain more than one component and the actual
antigen should be confirmed, the collection of proteins described
constitutes a unique antigen collection from these bacteria.
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